Form 8-K - Current report:
SEC Accession No. 0001213900-25-037822
Filing Date
2025-05-01
Accepted
2025-04-30 18:14:01
Documents
13
Period of Report
2025-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0240335-8k_longeveron.htm   iXBRL 8-K 26093
  Complete submission text file 0001213900-25-037822.txt   201576

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lgvn-20250424.xsd EX-101.SCH 3020
3 XBRL LABEL FILE lgvn-20250424_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE lgvn-20250424_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0240335-8k_longeveron_htm.xml XML 3794
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 25898328
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)